KF-0210

N/A

Report date: 2025/09/05 20:01:20
NME

Base Information

Drug NameKF-0210
Drug Alias NameKF-0210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor antagonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsSolid tumoursOsteoarthritis, KneeOsteoarthritis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesKeythera Pharmaceuticals (Australia) Pty Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKaifu (Suzhou) Biological Medicine Co LtdKeythera Pharmaceuticals (Australia) Pty Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursOsteoarthritis, KneeOsteoarthritis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank